UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052990
Receipt number R000060457
Scientific Title Exploratory study on the correlation between urinary biomarkers and oral function, and behavioral changes based on return of test results
Date of disclosure of the study information 2023/12/04
Last modified on 2024/04/17 09:53:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study on the correlation between urinary biomarkers and oral function, and behavioral changes based on return of test results

Acronym

Exploratory study on the correlation between urinary biomarkers and oral function, and behavioral changes based on return of test results

Scientific Title

Exploratory study on the correlation between urinary biomarkers and oral function, and behavioral changes based on return of test results

Scientific Title:Acronym

Exploratory study on the correlation between urinary biomarkers and oral function, and behavioral changes based on return of test results

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the correlation between urinary biomarkers and the oral environment in women in their 40s and 50s. In addition, evaluate the effect of returning test results on behavioral changes in lifestyle habits.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Urinary biomarkers and oral indicators
Health questionnaire and VAS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

View test results

Interventions/Control_2

No intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate
2.Women who are 40 years old or more and under 60 years old

Key exclusion criteria

1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
3.Persons who were judged as inappropriate for study participants by the principal investigator
4.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Mari
Middle name
Last name Shimura

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

0368092722

Email

shimura.mari@hc-sys.jp


Public contact

Name of contact person

1st name Mari
Middle name
Last name Shimura

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

0368092722

Homepage URL


Email

shimura.mari@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kurume Leading Project

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18 Shirakane, Showa-ku, Nagoya city, Aichi, JAPAN

Tel

0368092722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 12 Month 04 Day

Date of IRB

2023 Year 12 Month 04 Day

Anticipated trial start date

2023 Year 12 Month 05 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 12 Month 04 Day

Last modified on

2024 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060457